COVID-19

Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on February 25

RAMAT GAN, Israel, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing…

11 months ago

Tilray Brands Enhances Global Cannabis Supply Chain

Tilray Increases Industry-Leading Capacity to Meet Global Demand, Driving Growth Across Canada and EuropeNEW YORK and LEAMINGTON, Ontario, Feb. 10,…

11 months ago

Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference

Two presentations at ISC build on a growing body of data demonstrating the value of AI-powered portable MR images in…

11 months ago

AIM ImmunoTech announces a planned follow-up clinical study evaluating a combination treatment of AIM’s Ampligen® and AstraZeneca’s FluMist® to address the recent avian influenza outbreaks

Planned Investigational New Drug application to expand on previous clinical work at the University of Alabama-Birmingham in which administration of…

11 months ago

Hernando Ruiz-Jimenez assumes chief marketing and communications officer role at Geisinger

DANVILLE, Pa., Feb. 6, 2025 /PRNewswire/ -- Hernando Ruiz-Jimenez is Geisinger's new chief marketing and communications officer, a role in which…

11 months ago

COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration

WEXFORD, Pa., Feb. 6, 2025 /PRNewswire/ -- COEPTIS, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a pioneering technology company dedicated…

11 months ago

Universal Technical Institute Reports Fiscal Year 2025 First Quarter Results

Delivers Financial and Operational Outperformance in Fiscal Q1; Raises Fiscal 2025 Guidance Ranges for All Metrics PHOENIX, Feb. 5, 2025…

11 months ago

FM:Systems Study Finds 81% of Business Leaders Have Reached or Are Nearing a “New Normal” Five Years After COVID-19, Balancing Business Priorities and Employee Needs

FM:Systems 2025 Inside the Workplace Report Highlights: 76% of organizations are preparing to deploy generative artificial intelligence (GenAI) and 46%…

11 months ago

Erasmus Medical Center Safety Committee Grants Approval to Proceed with Phase 2 Study of Ampligen® and Imfinzi as a Potential Combination Therapy for Late-Stage Pancreatic Cancer

Safety Committee approval based on positive Phase 1 safety data demonstrating the combination therapy to be generally well-tolerated with no…

11 months ago

Celebrating the Winners of the Inaugural Sony Women in Technology Award with Nature

NEW YORK and LONDON and BERLIN and TOKYO, Feb. 4, 2025 /PRNewswire/ -- Sony Group Corporation (Sony) and Nature are proud…

11 months ago